Cédric Berger

Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes.

UI Investissement is a private equity investment manager focused on French small and medium-sized companies across sectors, who pays particular attention to sectors related to industry and services. The firm describes their investment approach as pragmatic and emphasizing mutual respect between the management in place and UI Investissement's team. The firm invests in companies valued between 10 and 100 million Euros, and targets expansion financing, shareholding restructuring and corporate succession situations leading to buyout transactions. They acquire minority interests when financing internal growth or acquisitions, and majority stakes in the case of LBO transactions. Investment criteria include market leadership potential, a clear competitive advantage and a growth-focused management team.

NCI invests in companies located in France with an enterprise value of EUR 20 - 100 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early, growth, MBO, MBI and OBO transactions with an investment size of EUR 3 - 15 million. The firm also acquires majority and minority interest.

Functions as a College/University

Provides software in clinical trials solutions

Functions as a College/University

Extens is an active manager which provides equity financing in small and medium-sized companies located in France, United Kingdom, and Germany. The firm targets technology companies working on software and applications within health sector. It invests between EUR 1 million and EUR 7 million through growth capital transactions in companies with revenues above EUR 1 million. Extens looks to take minority stake positions in its investments.

ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments.